142 related articles for article (PubMed ID: 21520098)
1. Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F; Tachezy M; Effenberger K; von Loga K; Zander H; Marx A; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Oncol; 2011 Aug; 104(2):140-5. PubMed ID: 21520098
[TBL] [Abstract][Full Text] [Related]
2. High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma.
Wang L; Chen W; Gao L; Yang Q; Liu B; Wu Z; Wang Y; Sun Y
World J Surg Oncol; 2012 Oct; 10():212. PubMed ID: 23039915
[TBL] [Abstract][Full Text] [Related]
3. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma.
Maréchal R; Demetter P; Nagy N; Berton A; Decaestecker C; Polus M; Closset J; Devière J; Salmon I; Van Laethem JL
Br J Cancer; 2009 May; 100(9):1444-51. PubMed ID: 19352387
[TBL] [Abstract][Full Text] [Related]
4. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
[TBL] [Abstract][Full Text] [Related]
5. Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma.
Liu Z; Teng XY; Meng XP; Wang BS
World J Surg Oncol; 2014 Nov; 12():348. PubMed ID: 25407240
[TBL] [Abstract][Full Text] [Related]
6. Expression of C-X-C motif chemokine receptors 4 and 7 in salivary gland neoplasms.
Phattarataratip E; Dhanuthai K
Arch Oral Biol; 2017 Nov; 83():136-144. PubMed ID: 28772134
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
Neve Polimeno M; Ierano C; D'Alterio C; Simona Losito N; Napolitano M; Portella L; Scognamiglio G; Tatangelo F; Maria Trotta A; Curley S; Costantini S; Liuzzi R; Izzo F; Scala S
Cell Mol Immunol; 2015 Jul; 12(4):474-82. PubMed ID: 25363530
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma.
Chifu I; Heinze B; Fuss CT; Lang K; Kroiss M; Kircher S; Ronchi CL; Altieri B; Schirbel A; Fassnacht M; Hahner S
Front Endocrinol (Lausanne); 2020; 11():597878. PubMed ID: 33281749
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of CXCR4 and CXCR7 with various stem cell markers in paired human primary and recurrent glioblastomas.
Flüh C; Hattermann K; Mehdorn HM; Synowitz M; Held-Feindt J
Int J Oncol; 2016 Apr; 48(4):1408-16. PubMed ID: 26821357
[TBL] [Abstract][Full Text] [Related]
14. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
15. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway.
Dieckow J; Brandt W; Hattermann K; Schob S; Schulze U; Mentlein R; Ackermann P; Sel S; Paulsen FP
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):56-65. PubMed ID: 26780310
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma.
Goto M; Shibahara Y; Baciu C; Allison F; Yeung JC; Darling GE; Liu M
Ann Surg Oncol; 2021 Sep; 28(9):4943-4951. PubMed ID: 33709176
[TBL] [Abstract][Full Text] [Related]
18. CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
Moreno MJ; Gallardo A; Novelli S; Mozos A; Aragó M; Pavón MÁ; Céspedes MV; Pallarès V; Falgàs A; Alcoceba M; Blanco O; Gonzalez-Díaz M; Sierra J; Mangues R; Casanova I
PLoS One; 2018; 13(6):e0198789. PubMed ID: 29920526
[TBL] [Abstract][Full Text] [Related]
19. CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.
Schrevel M; Karim R; ter Haar NT; van der Burg SH; Trimbos JB; Fleuren GJ; Gorter A; Jordanova ES
Br J Cancer; 2012 Apr; 106(9):1520-5. PubMed ID: 22531719
[TBL] [Abstract][Full Text] [Related]
20. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
